VCP
AVNS

Verus Capital Partners’s Avanos Medical AVNS Stock Holding History

Verus Capital Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1K Hold
43
– – ﹤0.01% 1389
2019
Q4 		$1K Buy
+43
New +$1.56K ﹤0.01% 1464

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Verus Capital Partners's AVNS Position: Q1 2020 in Review

Verus Capital Partners held its Avanos Medical (AVNS) position steady in Q1 2020 at 43 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

Verus Capital Partners first reported a position in AVNS in Q4 2019 and has held it in 2 quarters since. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Verus Capital Partners held 43 shares of Avanos Medical worth $1K as of Q1 2020.
  • Verus Capital Partners left its Avanos Medical share count unchanged in Q1 2020.
  • Avanos Medical made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1389 holding.
  • Verus Capital Partners first reported a position in Avanos Medical in Q4 2019 and has held it in 2 quarters since.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.